Ads
related to: pfizer- Astellas Pharma Support
Learn about our Support Solutions
and find helpful enrollment forms.
- World-Class Products
Discover more about our FDA-
approved treatment options.
- Science and Innovation
View our approach to finding
solutions for cancer's complexities
- Patient Commitment
Our Patient Centricity Team aims to
change the course of cancer care.
- Astellas Pharma Support
Search results
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters· 5 days agoModerna said on Friday the European Patent Office had upheld the validity of one of the company's...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
Reuters· 5 days ago, opens new tab $107.5 million in damages, a Delaware federal jury said on Friday after finding that...
This overlooked obesity-drug stock has 80% upside, JPMorgan says
Business Insider via Yahoo Finance· 8 hours agoJPMorgan said early results suggest the drug candidate offers "on par" weight loss results for...
Spotlight on Pfizer: Analyzing the Surge in Options Activity - Pfizer (NYSE:PFE)
Benzinga· 6 days agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE , and it's something market players shouldn't ignore. Our tracking of public ...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks· 5 days agoFree Report) has recently been on Zacks.com's list of the most searched stocks. The Zacks Large Cap Pharmaceuticals industry, to which Pfizer belongs, has gained 6.3% over ...
3 Healthcare Stocks to Buy Now: May 2024
InvestorPlace· 15 hours agoIt’s a great time to be looking at healthcare stocks to buy now. According to research from BlackRock, U.S. healthcare stocks have outperformed the...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga· 5 days agoModerna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO)...
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 22 hours agoA decade ago, as British drugmaker AstraZeneca fought off a hostile takeover bid by Pfizer, CEO Pascal Soriot made a big promise: The company, he said,...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
AOL· 5 days agoAstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its ...
3 Blue-Chip Stocks to Buy on the Dip: May 2024
InvestorPlace· 21 hours agoWhile the latest Commerce Department report showed a notable deceleration in GDP growth, experts attribute much of this to robust spending on imported...